Agonists determine the pattern of G-protein activation in μ-opioid receptor-mediated supraspinal analgesia

Brain Research Bulletin

Volumn 54, Issue 2, 2001, Pages 229-235

  Sánchez Blázquez, Pilar ^a   Gómez Serranillos, Pilar ^b   Garzón, Javier ^a  

^a INSTITUTO CAJAL   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Opioid agonists; Antisenseoligodeoxynucleotides; GTP binding regulatory proteins; Opioid receptor G protein complexes

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; BUPRENORPHINE; DIAMORPHINE; GUANINE NUCLEOTIDE BINDING PROTEIN; METHADONE; MORPHINE; MU OPIATE RECEPTOR;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPINAL ANESTHESIA;

ANALGESICS, OPIOID; ANIMALS; BUPRENORPHINE; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; GTP-BINDING PROTEIN ALPHA SUBUNITS, GQ-G11; HEROIN; HETEROTRIMERIC GTP-BINDING PROTEINS; LATERAL VENTRICLES; MALE; METHADONE; MICE; MORPHINE; PAIN MEASUREMENT; RECEPTORS, OPIOID, MU;

EID: 0035862538     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0361-9230(00)00448-2     Document Type: Article

References (29)

1. 5]-enkephalin-μ-opioid receptor complexes demonstrated by cyclic AMP-dependent protein kinase phosphorylation
2. A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled β-adrenergic receptor
3. Location of regions of the opioid receptor involved in selective agonist binding
4. αN-acetyl derivatives of β-endorphin (1-31) and (1-37) regulate the supraspinal antinociceptive activity of different opioids in mice
5. Dissimilar efficacy of opioids to produce mu-mediated analgesia; Role of Gz and Gi2 transducer proteins
6. Mu-opioid receptors regulate pertussis toxin insensitive Gz and Gq transducer proteins in the production of supraspinal analgesia in the mouse
7. Opioids binding mu and delta receptors exhibit diverse efficacy in the activation of Gi2 and Gx/z transducer proteins in mouse periaqueductal gray matter
8. Influence of Gz and Gi2 transducer proteins in the activity of opioid agonists to μ receptors
9. In vivo modulation of G-proteins and opioid receptor function by antisense oligodeoxynucleotides
10. Molecular characterization of opioid receptors
11. A comparative study of physiological and subjective effects of heroin and morphine administered intravenously in postaddicts
12. Blood-brain barrier; Penetration of morphine, codeine, heroin and methadone after carotid injection
13. Mapping of opioid receptors using antisense oligodeoxynucleotides; Correlating their molecular biology and pharmacology
14. Pharmacological characterization of buprenorphine, a mixed agonist-antagonist with k3 analgesia
15. Heroin acts on different opioid receptors that morphine in Swiss-wester and ICR mice to produce antinociception
16. Opioid receptor selectivity of heroin given intracerebroventricularly differs in six strains of inbred mice
17. Agonist-specific coupling of a cloned Drosophila octopamine/tyramine receptor to multiple second messenger systems
18. Novel receptor mechanisms for heroin and morphine-6β-glucuronide analgesia
19. Pertussis toxin differentially reduces the efficacy of opioids to produce supraspinal analgesia in the mouse
20. Delta-opioid receptor subtypes activate inositol-signaling pathways in the production of antinociception
21. In vivo injection of oligodeoxynucleotides to Gα subunits and supraspinal analgesia evoked by mu and delta opioid agonists
22. Endomorphin-1 and endomorphin-2 show differences in their activation of mu opioid receptor-regulated G proteins in supraspinal antinociception in mice
23. Retention of heroin and morphine-6β-glucuronide analgesia in a new line of mice lacking exon 1 of MOR-1
24. Differential signal transduction by five splice variants of the PACAP receptor
25. Differential blockade of opioid analgesia by antisense oligodeoxynucleotides directed against various G protein α subunits
26. Further demonstration of kappa opioid binding site in the brain; Evidence for heterogeneity
27. Studies on μ and δ opioid receptor selectivity utilizing chimeric and site-mutagenized receptors
28. Activity of mu- and delta-selective opioid agonists in the guinea pig ileum preparation; Differentiation into peptide and nonpeptide classes with β-funaltrexamine
29. The third extracellular loop of the μ opioid receptor is important for agonist selectivity